摘要
目的分析不同降压药对高血压伴糖尿病的疗效。方法选取2010年1月～2012年12月在本院接受治疗的高血压患者96例,随机分为呋塞米组、卡托普利组和硝苯地平组各32例,分别采用呋塞米、卡托普利和硝苯地平治疗,观察3组的血压、脂联素和胰岛素抵抗水平。结果卡托普利组的降压效果较明显,好于呋塞米组和硝苯地平组的患者(P<0.05);卡托普利组的脂联素和胰岛素抵抗改善均优于其他两组(P<0.05)。结论卡托普利能明显改善高血压伴糖尿病患者的血压和预后。
Objective To discuss the clinical value of different hypotensor in the treatment of hypertensive patients with type 2 diabetes.Methods Ninety six hypertensive patients with type 2 diabetes from January 2010 to December 2012 in our hospital were chosen for this study,and were divided into furosemide group,captopril group and nifedipine group,32 cases in each group,the patients were conducted furosemide,captopril,nifedipine respectively,then blood pressure,adiponectin and insulin resistance were observed.Results The effect of reducing blood pressure in captopril group was better than that of the other two groups（P＆lt;0.05）.The improvement of the adiponectin and insulin resistance in captopril group were better than that of the other two groups （P＆lt;0.05）.Conclusion Captopril can improve the blood pressure and prognosis of the hypertensive patients with type 2 diabetes.
出处
《中国当代医药》
2013年第21期68-69,共2页
China Modern Medicine
关键词
高血压
糖尿病
降压药
Hypertension
Diabetes
Hypotensor
